Research and Clinical Trials

In recent years, Covenant has made it a priority to expand our cancer research program and clinical trial offerings. Through our affiliation with MD Anderson, Covenant has become a member of the NRG, an oncology non-profit research organization formed to conduct clinical research and share the results. This will give Covenant patients increased access to clinical trials of new treatments and procedures.

Benefits of Clinical Trials

  • They offer patients a chance to benefit from the latest cutting-edge therapies
  • They contribute to the expanding knowledge base of medicine
  • They result in new innovations that lead to earlier diagnosis of illness, minimized side effects and better outcomes

Recent clinical trials conducted by Covenant involved new approaches to the diagnosis of breast cancer, a new radiotherapy treatment for liver tumors, and a new drug to treat women with advanced or recurrent endometrial cancer.

Upcoming Clinical Trials

Some of the MD Anderson Study Opportunities to be conducted by Covenant in 2020 will focus on:

  • Targeted breast radiation
  • Targeted radiation for oligo-metastatic disease
  • Endometrial cancer
  • Non-small cell lung cancer
  • Advanced pancreatic cancer
  • Colon cancer